U.S. Markets close in 6 hrs 16 mins

GlycoMimetics (GLYC) Worth Watching: Stock Surges 13.1%

Zacks Equity Research

GlycoMimetics, Inc. GLYC was a big mover last session, as the company saw its shares rise over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company since Jun 3, as the stock is now down nearly 19%.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

GlycoMimetics currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.

GLYCOMIMETICS Price

GLYCOMIMETICS Price | GLYCOMIMETICS Quote

Another favorably placed stock in the Biotechnology industry is Eisai Co., Ltd. ESALY, sporting a Zacks Rank #1 (Strong Buy).

Is GLYC going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
EISAI CO LTD (ESALY): Free Stock Analysis Report
 
GLYCOMIMETICS (GLYC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research